Evidence map›Paper›PMID 40149987›Full record

ReviewBiomolecules2025

Inositol and PIP2/PIP3 Ratio: At the Crossroad of the Biodynamic Interface Between Cells and Their Microenvironment.

Guglielmo Lentini, Alessandro Querqui, Alessandro Giuliani, Roberto Verna, Mariano Bizzarri

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guglielmo LentiniSpace Biomedicine Laboratory, Department of Experimental Medicine, University Sapienza, 00161 Rome, Italy.ORCID 0009-0000-9773-4630
Alessandro QuerquiSpace Biomedicine Laboratory, Department of Experimental Medicine, University Sapienza, 00161 Rome, Italy.
Alessandro GiulianiEnvironment and Health Department, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-4640-804X
Roberto VernaSpace Biomedicine Laboratory, Department of Experimental Medicine, University Sapienza, 00161 Rome, Italy.ORCID 0000-0002-1869-3912
Mariano BizzarriSpace Biomedicine Laboratory, Department of Experimental Medicine, University Sapienza, 00161 Rome, Italy.ORCID 0000-0003-0408-4136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma membrane plays a pivotal role in orchestrating motility and invasive processes, as well as mitosis and genome expression. Indeed, specialized regions of the plasma membrane enriched in phosphoinositides-namely PIP2 and PIP3-can accommodate the requirements of the dynamic interface, which mediates the interplay between cells and their microenvironment. The fine-tuned balance between the two phosphoinositides is instrumental in regulating cytoskeleton organization, motility, ion channel activation, and membrane traffic. The balanced expression of PIP2/PIP3 fulfills these functions by activating pathways through several transporter and receptor proteins. These dynamic interactions modulate the interplay with the extracellular environment by decreasing/increasing their exposure on the cell surface. In this way, lipid structures can rapidly either dismiss or recruit specific proteins, eventually favoring their cooperation with membrane receptors and ion channels. Particularly, exposure of proteins can be managed through the internalization of plasma membrane segments, while receptor signaling can be desensitized by their removal from the cell surface. Notably, the equilibrium between PIP2 and PIP3 is largely dependent on inositol availability, as inositol addition enhances PIP2 content while reducing PIP3 via PI3K inhibition. Pharmacological modulation of PIP2/PIP3 balance promises to be an interesting target in different clinical settings.

Indexed as

Cellular MicroenvironmentInositolPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesAnimalsCell MembraneHumansSignal TransductionInositolphosphatidylinositol 3,4-diphosphatePhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol Phosphatesbiodynamic interfacemyo-inositolphosphatidylinositol 3,4,5-trisphosphate (PIP3)phosphatidylinositol 4,5-bisphosphate (PIP2)

Identifiers

PMID40149987
PMCPMC11940430

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.